KORVIA
Live / Allowed — Published for opposition (as of 17 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 11 Jul 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99280112
- Mark type
- Stylized text
- Filed
- 11 Jul 2025
- Published for opposition
- 17 Mar 2026
- Attorney of record
- Joseph I. Hirsch
Goods and services
- Class 005 — Pharmaceuticals: Prescription pharmaceutical preparations used to treat infectious diseases, cancer, pain, inflammation, neurological diseases, psychiatric conditions, dermatological diseases, gastrointestinal diseases, musculoskeletal diseases, endocrine and metabolic diseases, ophthalmologic diseases, reproductive diseases, and respiratory conditions; none of the foregoing being prescription pharmaceutical preparations for the treatment of conditions related to hearing or the human ears
Owner
- Newcastle Bioscience, LLC, Naples, FL, US
- Newcastle Bioscience, LLC, Naples, FL, US
Prosecution history
- 17 Mar 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Mar 2026 — PUBLISHED FOR OPPOSITION
- 11 Mar 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 24 Feb 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 24 Feb 2026 — EXAMINER'S AMENDMENT ENTERED
- 24 Feb 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 24 Feb 2026 — EXAMINERS AMENDMENT E-MAILED
- 24 Feb 2026 — EXAMINERS AMENDMENT -WRITTEN
- 01 Jan 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 01 Jan 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 01 Jan 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 05 Nov 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 05 Nov 2025 — NON-FINAL ACTION E-MAILED
- 05 Nov 2025 — NON-FINAL ACTION WRITTEN
- 28 Oct 2025 — ASSIGNED TO EXAMINER